AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27018883 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcorneal route
Number of subjects: 12
Study 27018883 — intervention group
Group type: COMPARATOR
Intervention: Pars plana route
Number of subjects: 12
Study 25365612 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg melatonin
Number of subjects: 60
Study 25365612 — intervention group
Group type: COMPARATOR
Intervention: 0.75 mg/kg midazolam
Number of subjects: 60
Study 22763212 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL 2% lignocaine (lidocaine)
Number of subjects: 206
Study 22763212 — intervention group
Group type: COMPARATOR
Intervention: 10 mL 0.5% bupivacaine
Number of subjects: 206
Study 19744284 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 176
Study 18929400 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic radical hysterectomy (RRH)
Number of subjects: 48
Study 18929400 — intervention group
Group type: COMPARATOR
Intervention: Open radical hysterectomy (ORH)
Number of subjects: 48
Study 16444853 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin monotherapy (1 mg/kg twice daily for 10‐18 days, then 1.5 mg/kg once daily until day 90)
Number of subjects: 40
Study 16444853 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin monotherapy
Number of subjects: 40
Study 16444853 — intervention group
Group type: COMPARATOR
Intervention: Warfarin group (enoxaparin 1.0 mg/kg twice daily as a bridge to warfarin)
Number of subjects: 40
Study 16444853 — intervention group
Group type: COMPARATOR
Intervention: Warfarin group
Number of subjects: 40
Study 16444853 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 11830607 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus etoposide or paclitaxel (exact dosage and duration not specified)
Number of subjects: 574
Study 10362172 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrone sulfate 1.25 mg + Medroxyprogesterone acetate 2.5 mg
Number of subjects: 568
Study 10362172 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrone sulfate 1.25 mg + Medroxyprogesterone acetate 5 mg
Number of subjects: 568
Study 10362172 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrone sulfate 1.25 mg + Medroxyprogesterone acetate 10 mg
Number of subjects: 568
Study 7543393 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonates
Number of subjects: 0
Study 7543393 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioisotopes
Number of subjects: 0
Study 7543393 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatments (bisphosphonates, radioisotopes, local treatments)
Number of subjects: 0
Study 1952146 — intervention group
Group type: EXPERIMENTAL
Intervention: Train-of-four (TOF) stimulation at 60 mA
Number of subjects: 51
Study 1952146 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-burst stimulation (DBS3,3) at 20, 30, 50, and 60 mA
Number of subjects: 51
Study 1952146 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-burst stimulation (DBS3,2) at 20, 30, 50, and 60 mA
Number of subjects: 51
Study 1952146 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual assessment of fade at low currents
Number of subjects: 51
Study 1952146 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative assessment of TOF and DBS
Number of subjects: 51
Study 1952146 — intervention group
Group type: EXPERIMENTAL
Intervention: Observer training level
Number of subjects: 51
Study 6753109 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin
Number of subjects: 106
Study 6753109 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 31778115 — intervention group
Group type: EXPERIMENTAL
Intervention: myCompass eMH program
Number of subjects: 43631
Study 27371291 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstrings tendon (HAM) graft
Number of subjects: 20
Study 27371291 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-patellar tendon-bone (BPTB) graft
Number of subjects: 20
Study 27371291 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 26074239 — intervention group
Group type: EXPERIMENTAL
Intervention: E. faecalis isolates from Chinese traditional food products
Number of subjects: 43
Study 26074239 — intervention group
Group type: EXPERIMENTAL
Intervention: E. faecalis isolates from acidic gruel
Number of subjects: 43
Study 26074239 — intervention group
Group type: EXPERIMENTAL
Intervention: E. faecalis isolates from dairy source
Number of subjects: 43
Study 26074239 — intervention group
Group type: EXPERIMENTAL
Intervention: All E. faecalis isolates
Number of subjects: 43
Study 23663518 — intervention group
Group type: EXPERIMENTAL
Intervention: LED application (irradiated for 30 s, energy received at each point 41.7 J)
Number of subjects: 30
Study 23663518 — intervention group
Group type: COMPARATOR
Intervention: Placebo application
Number of subjects: 30
Study 21859184 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic psychotherapy with transference interpretation
Number of subjects: 100
Study 21859184 — intervention group
Group type: COMPARATOR
Intervention: Dynamic psychotherapy without transference interpretation
Number of subjects: 100
Study 20481050 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural resonance electromagnetic therapy (SREMT) - 10-12 daily sessions of 43 minutes each on a Rematerp apparatus.
Number of subjects: 120
Study 20481050 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving the same medical and physiotherapeutic treatment without SREMT.
Number of subjects: 120
Study 17565788 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation of persistence
Number of subjects: 0
Study 17565788 — intervention group
Group type: COMPARATOR
Intervention: No prime (absence of persistence)
Number of subjects: 0
Study 15105203 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. midazolam (0.09 mg/kg)
Number of subjects: 125
Study 15105203 — intervention group
Group type: COMPARATOR
Intervention: Control (local anesthetic only)
Number of subjects: 125
Study 11193231 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 12
Study 11193231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 11193231 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine 50 mg
Number of subjects: 12
Study 11193231 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg
Number of subjects: 12
Study 9625132 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil extract (EPA 3.2 g, DHA 2.4 g)
Number of subjects: 18
Study 9625132 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil (placebo)
Number of subjects: 18
Study 7935997 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study 3065156 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon dilatation
Number of subjects: 65
Study 3065156 — intervention group
Group type: COMPARATOR
Intervention: Bougie dilatation
Number of subjects: 65
Study 30954341 — intervention group
Group type: EXPERIMENTAL
Intervention: High-nitrate salad (twice daily for 10 days)
Number of subjects: 10
Study 30954341 — intervention group
Group type: COMPARATOR
Intervention: Canned vegetable control (beans, corn, or peas)
Number of subjects: 10
Study 28502543 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 3447
Study 28502543 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 3447
Study 26721132 — intervention group
Group type: EXPERIMENTAL
Intervention: Shallow needling (once a day, 5 times a week for 6 weeks)
Number of subjects: 96
Study 26721132 — intervention group
Group type: COMPARATOR
Intervention: Medication (3 mg eszopiclone tablets orally before sleep, once every night for 6 weeks)
Number of subjects: 96
Study 23882870 — intervention group
Group type: EXPERIMENTAL
Intervention: Light cigarette (0.6 mg of nicotine, 8 mg of tar, and 9 mg of carbon monoxide)
Number of subjects: 22
Study 23882870 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular cigarette (0.9 mg of nicotine, 12 mg of tar, and 12 mg of carbon monoxide)
Number of subjects: 22
Study 21729284 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg) administered orally at 21:00 h for five consecutive days
Number of subjects: 452
Study 21729284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 452
Study 18997640 — intervention group
Group type: EXPERIMENTAL
Intervention: Slit-lamp biomicroscopy (SLB)
Number of subjects: 129
Study 18997640 — intervention group
Group type: COMPARATOR
Intervention: Photographic grading of fundus photographs (FP)
Number of subjects: 129
Study 16990197 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg
Number of subjects: 717
Study 16990197 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 717
Study 14961588 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual inspection with acetic acid (VIA) screening
Number of subjects: 78392
Study 14961588 — intervention group
Group type: COMPARATOR
Intervention: Control group (no VIA screening)
Number of subjects: 78392
Study 14961588 — intervention group
Group type: EXPERIMENTAL
Intervention: VIA screening
Number of subjects: 78392
Study 11685385 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 min of moderate intensity exercise on a stationary cycle
Number of subjects: 78
Study 11685385 — intervention group
Group type: COMPARATOR
Intervention: Waiting passively (control condition 1)
Number of subjects: 78
Study 11685385 — intervention group
Group type: COMPARATOR
Intervention: Watching a video (control condition 2)
Number of subjects: 78
Study 9221864 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nitroglycerine (0.2 percent glyceryl trinitrate ointment)
Number of subjects: 35
Study 9221864 — intervention group
Group type: COMPARATOR
Intervention: Topical anesthetic gel (lignocaine)
Number of subjects: 35
Study 8213579 — intervention group
Group type: EXPERIMENTAL
Intervention: rt-PA (10 mg bolus, followed by 50 mg in the first hour, and 20 mg/hour for the next 2 hours)
Number of subjects: 253
Study 8213579 — intervention group
Group type: COMPARATOR
Intervention: streptokinase (375,000 IU bolus, followed by 1,125,000 IU over 1 hour)
Number of subjects: 253
Study 8213579 — intervention group
Group type: EXPERIMENTAL
Intervention: rt-PA
Number of subjects: 253
Study 8213579 — intervention group
Group type: COMPARATOR
Intervention: streptokinase
Number of subjects: 253
Study 3583491 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenticonazole 2% cream
Number of subjects: 40
Study 3583491 — intervention group
Group type: COMPARATOR
Intervention: Miconazole 2% cream
Number of subjects: 40
Study 30969246 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS on F4
Number of subjects: 60
Study 30969246 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS on P4
Number of subjects: 60
Study 30969246 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS on F4
Number of subjects: 60
Study 30969246 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS on P4
Number of subjects: 60
Study 27563740 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely high stress in male students
Number of subjects: 442113
Study 27563740 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely high stress in female students
Number of subjects: 442113
Study 27563740 — intervention group
Group type: EXPERIMENTAL
Intervention: Conflict with a teacher (male students)
Number of subjects: 442113
Study 27563740 — intervention group
Group type: EXPERIMENTAL
Intervention: Trouble with parents (male students)
Number of subjects: 442113
Study 27563740 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer relationships (male students)
Number of subjects: 442113
Study 27563740 — intervention group
Group type: EXPERIMENTAL
Intervention: Conflict with parents (female students)
Number of subjects: 442113
Study 27563740 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer relationships (female students)
Number of subjects: 442113
Study 27563740 — intervention group
Group type: EXPERIMENTAL
Intervention: Appearance (female students)
Number of subjects: 442113
Study 27563740 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial difficulty (female students)
Number of subjects: 442113
Study 26898862 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional steroid injection combined with acid-suppressive therapy (experimental group)
Number of subjects: 88
Study 26898862 — intervention group
Group type: COMPARATOR
Intervention: Acid-suppressive therapy only (control group)
Number of subjects: 88
Study 24529580 — intervention group
Group type: EXPERIMENTAL
Intervention: Silodosin 8-mg once-daily (QD)
Number of subjects: 532
Study 24529580 — intervention group
Group type: COMPARATOR
Intervention: Silodosin 4-mg twice-daily (BID)
Number of subjects: 532
Study 22262012 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured warm-up program
Number of subjects: 14
Study 19618305 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator (rt‐PA, alteplase) for acute ischaemic stroke
Number of subjects: 1118
Study 17499988 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine therapy for breast cancer
Number of subjects: 0
Study 17499988 — intervention group
Group type: COMPARATOR
Intervention: Laboratory and hormone replacement studies
Number of subjects: 0
Study 15072701 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) doses of 450 microg and 400 microg
Number of subjects: 0
Study 15072701 — intervention group
Group type: EXPERIMENTAL
Intervention: Three mathematical correction methods
Number of subjects: 0
Study 15072701 — intervention group
Group type: EXPERIMENTAL
Intervention: None of the correction methods
Number of subjects: 0
Study 12358259 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneovenous shunt
Number of subjects: 0
Study 12358259 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-volume paracentesis
Number of subjects: 0
Study 12358259 — intervention group
Group type: COMPARATOR
Intervention: Model validation
Number of subjects: 0
Study 10188768 — intervention group
Group type: EXPERIMENTAL
Intervention: SIRS plasma
Number of subjects: 0
Study 10188768 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralizing SIRS plasma of granulocyte macrophage-colony-stimulating factor
Number of subjects: 0
Study 10188768 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human IL-10 (10 ng/mL)
Number of subjects: 0
Study 7493146 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (60 mg/kg, i.v.)
Number of subjects: 24
Study 7493146 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (5 ml)
Number of subjects: 24
Study 2672869 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-gauge needle
Number of subjects: 2
Study 2672869 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-gauge needle
Number of subjects: 2
Study 520877 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression
Number of subjects: 39
Study 520877 — intervention group
Group type: COMPARATOR
Intervention: Control group (no compression)
Number of subjects: 39
Study 30995433 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine + Exenatide (Iglar + GLP-1)
Number of subjects: 0
Study 30995433 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine (Iglar)
Number of subjects: 0
Study 30995433 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (GLP-1)
Number of subjects: 0
Study 28026920 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone sustained release (SR) 32 mg / Bupropion SR 360 mg + Comprehensive Lifestyle Intervention (CLI)
Number of subjects: 0
Study 28026920 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard diet/exercise advice)
Number of subjects: 0
Study 25827441 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 12.5 mg twice daily
Number of subjects: 1094
Study 25827441 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 5 mg twice daily
Number of subjects: 1094
Study 25827441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1094
Study 24438460 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus SFP 10‐14 UK
Number of subjects: 0
Study 24438460 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 22387567 — intervention group
Group type: EXPERIMENTAL
Intervention: Paricalcitol
Number of subjects: 272
Study 22387567 — intervention group
Group type: COMPARATOR
Intervention: Cinacalcet plus low-dose vitamin D
Number of subjects: 272
Study 19145426 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium laser ablation of the prostate (HoLAP) using VersaPulse 100‐W laser (2.0 J/50 Hz or 3.2 J/25 Hz)
Number of subjects: 86
Study 19145426 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium laser ablation of the prostate (HoLAP)
Number of subjects: 86
Study 17555693 — intervention group
Group type: EXPERIMENTAL
Intervention: Debridement (Group I, n=20)
Number of subjects: 40
Study 17555693 — intervention group
Group type: COMPARATOR
Intervention: No debridement (Group II, n=20)
Number of subjects: 40
Study 15459619 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education intervention (single-page form distributed at triage desk for 8 weeks)
Number of subjects: 860
Study 15459619 — intervention group
Group type: COMPARATOR
Intervention: Control group (no patient education intervention)
Number of subjects: 860
Study 11474913 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education program with toothpaste and toothbrushes
Number of subjects: 727
Study 11474913 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education program only
Number of subjects: 727
Study 11474913 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste and toothbrushes only
Number of subjects: 727
Study 11474913 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 727
Study 9571947 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation
Number of subjects: 19
Study 9571947 — intervention group
Group type: COMPARATOR
Intervention: General Anaesthesia
Number of subjects: 19
Study 8052457 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0
Study 1696670 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (4 doses: 1.25, 2.5, 5.0, and 10.0 mg administered by i.v. infusion over 40 min)
Number of subjects: 22
Study 1696670 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine during exercise
Number of subjects: 22
Study 1245165 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mg digoxin with 1100 mg magnesium-aluminium-silicate-hydrate (n=4)
Number of subjects: 9
Study 1245165 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.375 mg digoxin with 1100 mg magnesium-aluminium-silicate-hydrate (n=4)
Number of subjects: 9
Study 1245165 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mg digoxin with 1000 mg dimagnesium-aluminium-trisilicate (n=5)
Number of subjects: 9
Study 1245165 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.375 mg digoxin with 1000 mg dimagnesium-aluminium-trisilicate (n=5)
Number of subjects: 9
Study 30730816 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafast shear wave elastography (SWE)
Number of subjects: 15
Study 27640367 — intervention group
Group type: EXPERIMENTAL
Intervention: Word catheter
Number of subjects: 161
Study 27640367 — intervention group
Group type: COMPARATOR
Intervention: Marsupialisation
Number of subjects: 161
Study 26077126 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phosphate (SP)
Number of subjects: 13
Study 26077126 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phosphate (SP) + beetroot juice (BJ)
Number of subjects: 13
Study 24090749 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use (current use within 2 months)
Number of subjects: 4476
Study 24090749 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use (any use within 24 months)
Number of subjects: 4476
Study 24090749 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 4476
Study 24090749 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 4476
Study 24090749 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 4476
Study 24090749 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 4476
Study 24090749 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 4476
Study 22193345 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal epidural (CSE) analgesia
Number of subjects: 60
Study 22193345 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural (E) analgesia
Number of subjects: 60
Study 22193345 — intervention group
Group type: EXPERIMENTAL
Intervention: IV pethidine analgesia
Number of subjects: 60
Study 22193345 — intervention group
Group type: EXPERIMENTAL
Intervention: CSE using bupivacaine or lidocaine
Number of subjects: 60
Study 18807218 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy (NIRS)
Number of subjects: 23
Study 18700004 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment during an 8-week open-label, randomized, escalating dose Pharmacokinetic Phase
Number of subjects: 0
Study 18700004 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment during a 16-week Long-Term Effectiveness Phase
Number of subjects: 0
Study 18700004 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment during a 28-week double-blind Discontinuation Phase
Number of subjects: 0
Study 18700004 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment during an 8-week open-label Restabilization Phase
Number of subjects: 0
Study 18700004 — intervention group
Group type: COMPARATOR
Intervention: Lithium treatment during an 8-week double-blind, parallel-group, placebo-controlled Efficacy Phase
Number of subjects: 0
Study 18700004 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment during an open-label Long-Term Effectiveness lasting either 16 or 24 weeks
Number of subjects: 0
Study 15548718 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal administration of granulocyte macrophage-colony stimulating factor around the excision site of stage I primary melanoma tumors
Number of subjects: 0
Study 11796808 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype latex female condom
Number of subjects: 135
Study 11796808 — intervention group
Group type: COMPARATOR
Intervention: Reality female condom
Number of subjects: 135
Study 9495426 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron 0.5 mg
Number of subjects: 314